 |
|
bexarotene
A synthetic retinoic acid agent with potential antineoplastic, chemopreventive, teratogenic and embryotoxic properties. Bexarotene selectively binds to and activates retinoid X receptors (RXRs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, apoptosis of some cancer cell types, and tumor regression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | 3-methyl TTNEB | | | | US brand name: | | Targretin | | | | Code name: | | LGD1069 | | | | Chemical structure name: | | 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic acid | | |
|
|
